RD3 and neuroblastoma: Consistently, our own ChIP assays with primers targeting RD3 intron 1 showed that an anti-N-Myc antibody efficiently immunoprecipitated the RD3 gene intron 1 region enriched in Sp1-binding sites in BE(2)-C neuroblastoma cells (Figure 3E).